People: Regeneron Pharmaceuticals Inc (REGN.O)
REGN.O on Nasdaq
264.92USD
3:35pm EDT
264.92USD
3:35pm EDT
Price Change (% chg)
$-2.06 (-0.77%)
$-2.06 (-0.77%)
Prev Close
$266.97
$266.97
Open
$265.79
$265.79
Day's High
$269.78
$269.78
Day's Low
$263.67
$263.67
Volume
451,796
451,796
Avg. Vol
1,117,618
1,117,618
52-wk High
$283.99
$283.99
52-wk Low
$107.31
$107.31
Baker, Charles
Brief Biography
Mr. Charles A. Baker, J.D., is an Independent Director of Regeneron Pharmaceuticals, Inc., since February 1989. In September 2000, Mr. Baker retired as Chairman, President, and Chief Executive Officer of The Liposome Company, Inc., a biopharmaceutical company, a position he had held since December 1989. During his career, Mr. Baker served in a senior management capacity in various other pharmaceutical companies, including tenures as Group Vice President, Squibb Corporation (now Bristol-Myers Squibb Company) and President, Squibb International, and various senior executive positions at Abbott Laboratories and Pfizer Inc. Mr. Baker is a member of the board of directors of Progenics Pharmaceuticals, Inc., a biopharmaceutical company.
Basic Compensation
| Total Annual Compensation, | Long-Term Incentive Plans, | All Other, | Fiscal Year Total, |
|---|---|---|---|
| -- | -- | -- | -- |
Options Compensation
| Quantity | Market Value | |
|---|---|---|
| Excercisable | -- | -- |
| Unexercisable | -- | -- |
| Excercised | -- | -- |
| Name | Fiscal Year Total |
|---|---|
P. Roy Vagelos |
-- |
Leonard Schleifer |
30,047,100 |
Murray Goldberg |
9,623,070 |
Joseph LaRosa |
-- |
Daniel Van Plew |
2,188,990 |
Peter Powchik |
-- |
As Of 30 Dec 2012

